1. Home
  2. VYGR vs STRS Comparison

VYGR vs STRS Comparison

Compare VYGR & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.81

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$28.75

Market Cap

238.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
STRS
Founded
2013
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
227.2M
238.1M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
VYGR
STRS
Price
$3.81
$28.75
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
511.1K
26.8K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
512.50
EPS
N/A
0.82
Revenue
$10,135,000.00
$29,914,000.00
Revenue This Year
$34.04
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
N/A
$35.24
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$15.35
52 Week High
$5.55
$32.93

Technical Indicators

Market Signals
Indicator
VYGR
STRS
Relative Strength Index (RSI) 47.93 42.23
Support Level $3.71 $28.22
Resistance Level $4.39 $31.62
Average True Range (ATR) 0.27 0.68
MACD -0.03 -0.07
Stochastic Oscillator 40.23 37.35

Price Performance

Historical Comparison
VYGR
STRS

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.

Share on Social Networks: